Drug Approvals - Epidemiology

Relevant Publications

Impact of structural biology and the protein data bank on us fda new drug approvals of low molecular weight antineoplastic agents 2019-2023.

Issue Release: 2024

Innovation, affordability, access: Alzheimer disease drugs and the Inflation Reduction Act.

Issue Release: 2024

Schizophrenia interactome derived repurposable drugs and randomized control trials of two candidates.

Issue Release: 2024

Bispecific Antibody Use in Patients With Lymphoma and Multiple Myeloma.

Issue Release: 2024

Clinical Evidence Supporting FDA Approval of Gene and RNA Therapies for Rare Inherited Conditions.

Issue Release: 2024

Navigating Treatment Options and Communication in Relapsed Pediatric AML.

Issue Release: 2024

The preclinical discovery and development of atogepant for migraine prophylaxis.

Issue Release: 2024

Associations Between Surrogate Markers and Clinical Outcomes for Nononcologic Chronic Disease Treatments.

Issue Release: 2024

Targeted CQA analytical control strategy for commercial antibody products: Replacing ion-exchange chromatography methods for charge heterogeneity with multi-attribute monitoring.

Issue Release: 2024

National trends in prescription drug expenditures and projections for 2024.

Issue Release: 2024

MYTX-011: a pH-dependent anti-cMET antibody-drug conjugate designed for enhanced payload delivery to cMET expressing tumor cells.

Issue Release: 2024

Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors.

Issue Release: 2024

Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions.

Issue Release: 2024

Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives.

Issue Release: 2024

Additive Cytotoxic and Colony-Formation Inhibitory Effects of Aspirin and Metformin on -Mutant Colorectal Cancer Cells.

Issue Release: 2024

FGF21 Agonists: An Emerging Therapeutic for Metabolic Dysfunction-Associated Steatohepatitis and Beyond.

Issue Release: 2024

Second Line Therapy in Multiple Myeloma: A SEER Medicare Analysis.

Issue Release: 2024

Front-Line Therapeutic Strategy in Metastatic Hormone Sensitive Prostate Cancer: An Updated Therapeutic Algorithm.

Issue Release: 2024

Biomarkers for Precision Patient Selection in Cancer Therapy Approvals in the US, from 2011 to 2023.

Issue Release: 2024

Development and approval of novel injectables: enhancing therapeutic innovations.

Issue Release: 2024

Why is Animal Testing Important in Epidemiology?

What is Temporal Bias in Epidemiology?

What Measures Can Mitigate Financial Conflicts?

How Does Technology Impact Data Sharing?

How Do International Regulations Influence National Public Health Policies?

How Does Phenotypic Plasticity Influence Disease Spread?

Why Use Multiple Models?

What is TCF7L2?

What is GitHub?

What is Healthcare Financing?

Partnered Content Networks

Relevant Topics